Valuation Indivior Pharmaceuticals, Inc. London S.E.

Stocks

Delayed London S.E. Other stock markets 11:35:04 2025-07-24 EDT			5-day change	1st Jan Change
1,238.00 ^GBX	+1.56%		+5.27%	+20.90%

06-28	Indivior Pharmaceuticals, Inc.(NasdaqGS:INDV) added to Russell 2000 Value-Defensive Index	CI
06-28	Indivior Pharmaceuticals, Inc.(NasdaqGS:INDV) added to Russell 2000 Growth-Defensive Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,423	2,969	2,085	1,553	4,480	4,985	-	-
Change	-	22.54%	-29.76%	-25.5%	188.39%	11.29%	-	-
Enterprise Value (EV) ¹	1,563	2,435	2,008	1,567	4,604	5,040	4,582	4,057
Change	-	55.81%	-17.52%	-21.95%	193.72%	9.47%	-9.09%	-11.45%
P/E	12.8x	-57.2x	1,527x	-34.5x	21.9x	12.9x	11.3x	10.5x
PBR	-	59.3x	-	-8.02x	-45.8x	-	-	-
PEG	-	0x	-15x	0x	-0x	0.1x	0.8x	1.31x
Capitalization / Revenue	3.06x	3.29x	1.91x	1.31x	3.62x	3.96x	3.81x	3.63x
EV / Revenue	1.98x	2.7x	1.84x	1.32x	3.72x	4.01x	3.5x	2.95x
EV / EBITDA	7.74x	10.8x	6.97x	4.64x	10.8x	7.72x	6.64x	5.65x
EV / EBIT	8.36x	11.5x	7.47x	5.02x	11.1x	8.09x	6.9x	5.81x
EV / FCF	4.61x	-10.7x	-4.86x	-196x	-49.5x	14x	9.45x	7.54x
FCF Yield	21.7%	-9.32%	-20.6%	-0.51%	-2.02%	7.15%	10.6%	13.3%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	1.35	-0.38	0.01	-0.36	1.64	3.175	3.61	3.9
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	791	901	1,093	1,188	1,239	1,258	1,308	1,374
EBITDA ¹	202	225	288	338	428	652.9	690.5	718.4
EBIT ¹	187	212	269	312	415	623.3	664	698.8
Net income ¹	205	-53	2	-48	210	414.5	472.9	517.4
Net Debt ¹	-860	-534	-77	14	124	54.5	-403.4	-928
Reference price ²	17.25	21.75	15.27	12.43	35.88	40.89	40.89	40.89
Nbr of stocks (in thousands)	140,437	136,489	136,551	124,970	124,854	121,922	-	-
Announcement Date	2/16/22	2/16/23	2/22/24	2/20/25	2/26/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.46x	12.91x	26.29x	0.56%	1,084B
JOHNSON & JOHNSON	28.11x	6.45x	17.52x	2.03%	634B
ABBVIE INC.	30.45x	7.46x	15.28x	2.72%	447B
ROCHE HOLDING AG	17.81x	4.43x	10.97x	2.99%	330B
ASTRAZENECA PLC	23.78x	4.98x	13.89x	1.75%	295B
NOVARTIS AG	21.66x	5.57x	13.46x	2.83%	285B
NOVO NORDISK A/S	14.26x	5.31x	10.9x	3.51%	218B
AMGEN INC.	24.07x	6.37x	11.22x	2.74%	199B
GILEAD SCIENCES, INC.	-48.15x	5.84x	32.48x	2.39%	169B
Average	16.38x	6.59x	16.89x	2.39%	406.65B
Weighted average by Cap.	24.24x	8.02x	18.60x	1.95%